Option chain shows key data for Daxor's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Daxor.

Daxor (NASDAQ:DXR) Stock, Option Chain

Daxor

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ABSI

ADSE

AKBA

AULT

AVIR

AVRO

BIOC

BJDX

BXRX

CELU

CINT

CNSP

COCO

CRCT

ENVB

FLGC

HEPA

HSTO

ICPT

IMMX

IONQ

MBOT

MGRM

NBTX

NCPL

NUTX

OTLK

PRSO

QBTS

RAIN

RXRX

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SGTX

TRNR

UPST

VECT

VLCN

WAVD

ZVSA

Gainers


	Greenhill &amp; Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.


Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

FRGE

IZEA

MDNA

TORO

ZAPP

Gainers


	SeqLL Inc. (NASDAQ: SQL) shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss.


Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Earnings

Eurozone

Commodities

Global

CMND

FDMT

PEGY

POWW

TRUE

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday.

Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected

Daxor Corp

Press Releases

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Daxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025

Daxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024

Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and Expo

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better Survival

Daxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

HeartBeam

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

electroCore

Femasys

Fractyl Health

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Hyperfine

Iridex

Modular Medical

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Nexalin Technology

Owlet

PAVmed

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Vivani Medical

Beyond Air

Zynex

Ascendiant Capital

Comments

Daxor

Daxor (DXR) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell